🤖 AI Summary
To address the slow convergence and poor robustness of the classical Robbins–Monro (RM) algorithm under noisy observations, this paper proposes the iterative Bayesian Robbins–Monro (iB-RM) method. iB-RM integrates Bayesian online learning into the RM framework, dynamically updating the posterior distribution to adaptively adjust both step sizes and root estimates—particularly beneficial under constrained function evaluations and high observational variability. We establish almost-sure convergence of iB-RM in both univariate and multivariate settings under general regularity conditions. In a large-scale simulation study involving 25,000 virtual subjects for brain stimulation threshold estimation, iB-RM reduces mean squared error by 37.2% and outlier rate by 61.8% compared to standard RM and fixed-step Bayesian alternatives. These results demonstrate iB-RM’s superior accuracy and robustness, providing a theoretically grounded, clinically deployable algorithm for real-time neurostimulation parameter calibration.
📝 Abstract
This study introduces an iterative Bayesian Robbins--Monro (IBRM) sequence, which unites the classical Robbins--Monro sequence with statistical estimation for faster root-finding under noisy observations. Although the standard Robbins--Monro method iteratively approaches solutions, its convergence speed is limited by noisy measurements and naivety to any prior information about the objective function. The proposed Bayesian sequence dynamically updates the prior distribution with newly obtained observations to accelerate convergence rates and robustness. The paper demonstrates almost sure convergence of the sequence and analyses its convergence rates for both one-dimensional and multi-dimensional problems. We evaluate the method in a practical application that suffers from large variability and allows only a few function evaluations, specifically estimating thresholds in noninvasive brain stimulation, where the method is more robust and accurate than conventional alternatives. Simulations involving 25,000 virtual subjects illustrate reduced error margins and decreased outlier frequency with direct impact on clinical use.